Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

<p>Changes of cell types based on (a) MCP-Counter and (b) Danaher module with post- vs pre-treatment samples. All tests were performed by non-parametric Wilcoxon test.</p>

Saved in:
Bibliographic Details
Main Author: Tom Wei-Wu Chen (15053003) (author)
Other Authors: Chia-Lang Hsu (11929719) (author), Ruey-Long Hong (15053006) (author), Jen-Chieh Lee (14954275) (author), Koping Chang (15053009) (author), Chih-Wei Yu (15053012) (author), San-Chi Chen (15050106) (author), Jhe-Cyuan Guo (15053015) (author), Mei-Lu Chen (15053018) (author), Meng-Chi Hsu (15053021) (author), Ting-Fang Kung (15053024) (author), Ann-Lii Cheng (15045786) (author), Chueh-Chuan Yen (15053027) (author)
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849927634277892096
author Tom Wei-Wu Chen (15053003)
author2 Chia-Lang Hsu (11929719)
Ruey-Long Hong (15053006)
Jen-Chieh Lee (14954275)
Koping Chang (15053009)
Chih-Wei Yu (15053012)
San-Chi Chen (15050106)
Jhe-Cyuan Guo (15053015)
Mei-Lu Chen (15053018)
Meng-Chi Hsu (15053021)
Ting-Fang Kung (15053024)
Ann-Lii Cheng (15045786)
Chueh-Chuan Yen (15053027)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author_facet Tom Wei-Wu Chen (15053003)
Chia-Lang Hsu (11929719)
Ruey-Long Hong (15053006)
Jen-Chieh Lee (14954275)
Koping Chang (15053009)
Chih-Wei Yu (15053012)
San-Chi Chen (15050106)
Jhe-Cyuan Guo (15053015)
Mei-Lu Chen (15053018)
Meng-Chi Hsu (15053021)
Ting-Fang Kung (15053024)
Ann-Lii Cheng (15045786)
Chueh-Chuan Yen (15053027)
author_role author
dc.creator.none.fl_str_mv Tom Wei-Wu Chen (15053003)
Chia-Lang Hsu (11929719)
Ruey-Long Hong (15053006)
Jen-Chieh Lee (14954275)
Koping Chang (15053009)
Chih-Wei Yu (15053012)
San-Chi Chen (15050106)
Jhe-Cyuan Guo (15053015)
Mei-Lu Chen (15053018)
Meng-Chi Hsu (15053021)
Ting-Fang Kung (15053024)
Ann-Lii Cheng (15045786)
Chueh-Chuan Yen (15053027)
dc.date.none.fl_str_mv 2025-11-25T12:42:28Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30705873
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Supplementary_Figure_3_from_A_Single-Arm_Phase_Ib_II_Study_of_Lenvatinib_plus_Eribulin_in_Advanced_Liposarcoma_and_Leiomyosarcoma/30705873
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Sarcomas
Soft-tissue sarcoma
Translational Research
dc.title.none.fl_str_mv Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Changes of cell types based on (a) MCP-Counter and (b) Danaher module with post- vs pre-treatment samples. All tests were performed by non-parametric Wilcoxon test.</p>
eu_rights_str_mv openAccess
id Manara_3dedb9dafa20ac0a4513424e9cbedef1
identifier_str_mv 10.1158/1078-0432.30705873
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30705873
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and LeiomyosarcomaTom Wei-Wu Chen (15053003)Chia-Lang Hsu (11929719)Ruey-Long Hong (15053006)Jen-Chieh Lee (14954275)Koping Chang (15053009)Chih-Wei Yu (15053012)San-Chi Chen (15050106)Jhe-Cyuan Guo (15053015)Mei-Lu Chen (15053018)Meng-Chi Hsu (15053021)Ting-Fang Kung (15053024)Ann-Lii Cheng (15045786)Chueh-Chuan Yen (15053027)CancerTherapeutic Research and DevelopmentClinical Research and TrialsClinical Trial ResultsPhase II clinical trialsSarcomasSoft-tissue sarcomaTranslational Research<p>Changes of cell types based on (a) MCP-Counter and (b) Danaher module with post- vs pre-treatment samples. All tests were performed by non-parametric Wilcoxon test.</p>2025-11-25T12:42:28ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30705873https://figshare.com/articles/figure/Supplementary_Figure_3_from_A_Single-Arm_Phase_Ib_II_Study_of_Lenvatinib_plus_Eribulin_in_Advanced_Liposarcoma_and_Leiomyosarcoma/30705873CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307058732025-11-25T12:42:28Z
spellingShingle Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Tom Wei-Wu Chen (15053003)
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Sarcomas
Soft-tissue sarcoma
Translational Research
status_str publishedVersion
title Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
title_full Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
title_fullStr Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
title_full_unstemmed Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
title_short Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
title_sort Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
topic Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Sarcomas
Soft-tissue sarcoma
Translational Research